Recently added articles from Pharmaceutical Technology Europe:
Swiss company eyes cancer treatment
Apr 01, 2008; Anonymous ... R&D Cancerous tumour growth can be reduced by 69% according to comparative preclinical studies by a company based in Geneva (Switzerland). Anavex 7-1037 is Anavex's lead candidate in its attempt to develop a treatment for a number of cancers, including cancer of the breast, colon, ...
The end of an era...
Apr 01, 2008; Campos-Seijo, Bibiana ... It is the end of an era. Building on more than 6 years of dedication and hard work, Gurminder Marwaha has left Pharmaceutical Technology Europe (PTE) in search of new challenges. As his successor, é would like to join all the members of the editorial team in wishing him every ...
Europe struck by heparin scare
Apr 01, 2008; Anonymous ... Industry EC admits patients are at increasing risk of noncompliants Heparin, already responsible for deaths in the US, has now been tied to several adverse reactions in Germany, and there are now concerns that the heparin scare could become a global problem, in the US, the deaths ...
Experts in GXP Conferences & Seminars
Apr 01, 2008; Anonymous ... * APIs: CERTIFY YOUR ACTIVE SUBSTANCES AS GMP COMPLIANT 15 & 16 May London Ref. M5-6108 * TECHNOLOGY LICENSING Fundamentals and Strategy for Maximising Value of Intellectual Capital 23 & 24 June London Ref. H6-5108 * ...
Sanofi welcomes Swedish vaccine choice
Apr 01, 2008; Anonymous ... Regulatory The recommendation from health authorities in Sweden to vaccinate all young girls in Sweden against cervical cancer has been described as "great news" by Sanofi Pasteur. The Swedish National Board of Health and welfare is pushing for the universal free vaccination of all girls ...
TB drug resistance on the rise
Apr 01, 2008; Anonymous ... Industry Billions needed to control the disease Multidrug-resistant tuberculosis (MDR-TB) has been recorded at the highest rates ever, according to a new report. "TB drug resistance needs a frontal assault. If countries and the international community fail to address it ...
Prepare for policy changes
Apr 01, 2008; Anonymous ... Regulatory A report has been delivered to the German government that could lead to one of the most significant revisions of drug policy procedure in Europe in more than a decade. The 70-page report, commissioned last year by Germany's Institute for Quality and Efficiency in Healthcare, ...
The UK must be more innovative
Apr 01, 2008; Anonymous ... Industry A new paper published by the British government has argued that innovation is essential to the UK's future prosperity and has pledged £150 million (euro195.3 million) to industry. AS an immediate step, each government department will publish an Innovation Procurement Plan as ...
Water, water everywhere?
Apr 01, 2008; Aldridge, Susan ... The looming threat of a water supply crisis means that pharma and biotech manufacturers must take their water footprint as seriously as their carbon footprint. Clean water is an increasingly precious resource, and there are huge inequities in water use around the world; for example, 700 ...
East meets West
Apr 01, 2008; Miller, Jim ... As pharmaceutical companies extend their supply chains, more contract manufacturing organizations and research organizations are globalizing their operations. The pharmaceutical industry was rattled last month when it was reported that several batches of heparin manufactured and marketed ...
The problem with stents
Apr 01, 2008; Bentley, Justine ... CSMA searches for the key surface issues in drug-eluting stents that cause variation in release timings and, ultimately, impinge on intended medical effects. Our company is involved in developing and manufacturing APIs that can be utilized with drug-eluting stents (DES). Despite ensuring ...
Enhanced brain drug delivery and targeting
Apr 01, 2008; Rautio, Jarkko; Laine, Krista; Gynther, Mikko ... An examination of the drug analogs and p rod rugs of small molecules that utilize either large neutral amino acid or glucose transporters of the BBB in their brain penetration. The blood-brain barrier (BBB) forms an interface between the circulating blood and the brain, and functions as ...
20th Century Anniversary Special Feature Outsourcing biologics manufacturing
Apr 01, 2008; Ellison, Derek ... This article reviews how today's contract biomanufacturing industry has developed to overcome the technical and commercial challenges of the past 20 years. Biopharmaceuticals are the most rapidly growing segment of the pharmaceutical market. Developing and marketing biopharmaceuticals ...
Out of Africa: the pharma challenge
Apr 01, 2008; Smith, Deryck ... Africa faces a barrage of challenges in its search for cheaper medicines, and so too do pharmaceutical companies. Traditionally, African countries have imported drugs from countries where the prices are cheaper, such as India and China. However, the tightening of regulatory and patent ...
Solid dosage forms from self-emulsifying lipidic formulations
Apr 01, 2008; Marchaud, Delphine; Hughes, Sophie ... Lipid excipients present a problem for tablet dosage forms, but bioavailability enhancing liquid and semi-solid formulations can change that. There has been growing interest in the use of lipidic excipients in formulations and, in particular, in self-emulsifying lipid formulations ...
Developing cold chain solutions
Apr 01, 2008; Thomas, Geraint ... With huge costs at stake, an unbroken cold chain is essential for transporting temperature sensitive pharmaceuticals. Do you know the best methods to ensure the safety of your products? When shipping temperature-sensitive pharmaceutical, maintaining an unbroken cold chain is essential to ...
Water sorption unit
Apr 01, 2008; Anonymous ... Editor's product of the month A new dynamic gravimetric water sorption analyser for small- to medium-sized laboratories is available from Surface Measurement Systems (SMS). The DVS intrinsic combines SMS Ultrabalance technology with unsurpassed humidity and temperature control to provide ...
Lifting truck
Apr 01, 2008; Anonymous ... Atlet's new Tergo reach truck is stronger and quieter than previous models, and features greatly-enhanced performance, safety and ergonomics. Forte UNS Tergo is available with lift capacities of 1400,1600 and 2000 kg, and standard lift heights of up to 10.8 m. Driving speed has increased by16% ...
Dissolution testing with UV fibre optics
Apr 01, 2008; Anonymous ... Omicron Research's Opt Diss fibre optic ultra-violet dissolution testing system takes analysis directly into the vessel where dissolution occurs. The use of fibre optics negates the need for sample removal, and offers unproved precision and accuracy of test measurements, while also eliminating ...
Stem cell theory challenged
Apr 01, 2008; Anonymous ... New alternative to controversial technology offered An alternative to controversial stem cell therapy could be provided by patented technology that extracts mature white blood cells from veins and turns them into cells with programmable properties comparable to those of stem cells. The ...